March 24, 2015
A health ministry committee agreed on March 20 that Kitasato Daiichi Sankyo Vaccine will continue the cell culture-based vaccine production project for new strains of influenza. Kitasato Daiichi Sankyo Vaccine was selected to build a cell culture-based vaccine supply system...read more